| Clayton G Zeidler, DDS | |
|
5150 Graves Ave, Suite 10a, San Jose, CA 95129-5013 | |
| (408) 257-3530 | |
| (408) 257-0341 |
| Full Name | Clayton G Zeidler |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 5150 Graves Ave, San Jose, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063430049 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 49035 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Clayton G Zeidler, DDS 5150 Graves Ave, Suite 10a, San Jose, CA 95129-5013 Ph: (408) 257-3530 | Clayton G Zeidler, DDS 5150 Graves Ave, Suite 10a, San Jose, CA 95129-5013 Ph: (408) 257-3530 |
News Archive
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces the publication of an article, entitled "A novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: a case series," authored by Dr. Matthew C. Foote, Dr. Bryan H. Burmeister, Janine Thomas, and Dr. B. Mark Smithers, in the current issue of the peer-reviewed journal, Melanoma Research (20(1):48-51, February 2010).
Millipore Corporation, a leading provider of technologies, tools and services for the global life science industry, today announced that its shareholders voted at a Special Meeting of Shareholders to approve the previously-announced acquisition of all outstanding shares of common stock of Millipore by Merck KGaA of Germany, the global pharmaceutical and chemical company.
Life Technologies Corporation today announced that it is the first life science tools provider entering clinical trials to prove the safety and effectiveness of their DNA sequence-based typing (SBT) platform for analysis of the Human Leukocyte Antigen (HLA) system. Submission for 510(k) clearance of this SBT platform will follow completion of the clinical trials, which is anticipated this summer.
Using a combination of genetic linkage, microarray gene expression and genetic association studies, a group of Brigham and Women's Hospital/ Harvard Medical School researchers have identified a serine protease inhibitor clade E, member 2, or SERPINE2, "as a novel candidate susceptibility gene for COPD," according to Sorachai Srisuma
Researchers at the University of Oklahoma Health Sciences Center have found a way to use a radical new type of gene therapy to prevent blindness caused by retinitis pigmentosa, giving hope to the estimated 100,000 Americans who suffer from this debilitating disease.
› Verified 4 days ago
Nam Hoai Nguyen, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 459 S Capitol Ave, San Jose, CA 95127 Phone: 408-923-4989 | |
Dr. Rosemary Evans, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2680 S White Road, Suite 100, San Jose, CA 95148 Phone: 408-531-9881 Fax: 408-531-9580 | |
Dr. Huong Thi Mai Nguyen, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 1657 Mckee Rd Ste 40, San Jose, CA 95116 Phone: 408-937-9229 Fax: 408-937-6169 | |
Magdalena Azzarelli, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1660 Hillsdale Ave, 130, San Jose, CA 95124 Phone: 408-267-2550 Fax: 408-267-1411 | |
Dr. Aparna R. Naik, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 850 Saratoga Ave Apt E307, San Jose, CA 95129 Phone: 408-833-7992 | |
Dr. Arline G Guinto Macaraeg, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 125 N Jackson Ave, Suite 207, San Jose, CA 95116 Phone: 408-258-9943 Fax: 408-258-9951 | |
Dr. Cory Timbers, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 155 N Jackson Ave, Suite 202, San Jose, CA 95116 Phone: 408-251-3766 |